Hungry bone syndrome. Report of four cases;Síndrome de "huesos hambrientos": Experiencia clínica en su diagnóstico y tratamiento

Revista Medica de Chile

Volumn 128, Issue 1, 2000, Pages 80-85

  Araya Q, Verónica ^a,b   Oviedo G, Sofía ^a   Amat V, José ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Bone resorption; Hyperparathyroidism; Hypocalcemia; Hypophosphatemia

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; BONE REGENERATION; CASE REPORT; FEMALE; HUMAN; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPHOSPHATEMIA; MAGNESIUM DEFICIENCY; MIDDLE AGED; PARATHYROID TUMOR; PARATHYROIDECTOMY; POSTOPERATIVE CARE; SYNDROME;

ADENOMA; ADULT; AGED; BONE REGENERATION; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPHOSPHATEMIA; MAGNESIUM DEFICIENCY; MIDDLE AGED; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; POSTOPERATIVE CARE; SYNDROME;

EID: 0033650565     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. HARDOFF R, FRAJEWICKI V. Bone scintigraphy in Hungry Bone Syndrome following parathyroidectomy. J Nucl Med 1996; 37: 1371-3.
2. BOECHAT MI, WESTRA SJ, VAN DOP C, KAUFMAN F, GILSANZ V, ROE TF. Decreased cortical and increased cancellous bone in two children with primary hyperparathyroidism. Metabolism 1996; 45: 76-81.
3. BRASIER A, NUSSBAUM S. Hungry bone syndrome: Clinical and biochemical predictors of its ocurrence after parathyroid surgery. Am J Med 1988; 84: 654-660.
4. SAVAZZI GM, ALLEGRI L. The hungry bone syndrome: Clinical problems and therapeutic approaches following parathyroidectomy. Eur J Med 1993; 2: 363-8.
5. CRUZ DN, PERAZELLA MA. Biochemical aberrations in a dialysis patient following parathyroidectomy. Am J Kidney Dis 1997; 29: 759-62.
6. LÓPEZ JM, SAPUNAR J, CAMPUSANO C, ARTEAGA E, RODRÍGUEZ JA ET AL. Cambio en la presentación clínica del hiperparatiroidismo primario. Análisis de 84 casos. Rev Méd Chile 1993; 121: 265-72.
7. ALBRIGHT F, REIFENSTEIN EC JR. The parathyroid glands and metabolic bone disease. Baltimore: Williams and Wilkins, 1948.
8. PUMARINO H, CAMPINO C, OVIEDO S, FERREIRO F, GENERINI G. Hiperparatiroidismo primario: experiencia con 30 pacientes. Rev Méd Chile 1982; 110: 1197-203.
9. LÓPEZ JM, GONZÁLEZ G. Hiperparatiroidismo primario asintomático: evaluación de la masa ósea por densitometría ósea bifotónica. Rev Méd Chile 1992; 120: 282-7.
10. KALE N, BASAKLAR AC, SONMEZ K, ULUOGLU O, DEMIRSOY S. Hungry bone syndrome in a child following parathyroid surgery. J Pediatr Surg 1992; 27: 1502-3.
11. GRAAL MB, WOLFFENBUTTEL BHR. Consequences of long-term hyperparathyroidism. NJM 1998; 53: 37-42.
12. DAMIANI D, AGUIAR CH, BUENO VS, MONTENEGRO FL, KOCH VH, COCOZZA AM ET AL. Primary hyperparathyroidism in children: patient report and review of the literature. J Pediatr Endocrinol Metab 1998; 11: 83-6.
13. HEADLEY CM. Hungry bone syndrome following parathyroidectomy. ANNA 1998; 25: 283-9.
14. ROLAND E. Anesthesie-reanimation pour chirurgie des glandes parathyroides. Ann Chir 1999; 53: 150-61.
15. RUDE RK, OLDHAM SB, SINGER FR. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 1976; 5: 209-24.
16. FATEMI S, RYZEN E, FLORES J, ENDRES DB, RUDE RK. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991; 73: 1067-72.
17. RUDE RK, ADAMS JS, RYZEN E, ENDRES DB, NIIMI H, HORST RL ET AL. Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab 1985; 6: 933-40.
18. CLAIR F, LEEHARDT L, BOURDEAU A, IZINGRAFF J, ROBERT D, DUBOST C ET AL. Effect of calcitriol in the control of plasma calcium after parathyroidectomy. A placebo-controlled, double-blind study in chronic hemodialysis patients. Nephron 1987; 46: 18-22.
19. LLACH F. Parathyroidectomy in chronic renal failure: Indications, surgical approach and the use of calcitriol. Kidney Int Suppl 1990; 29: S62-S68.
20. KUMAR A, RALSTON SH. Bisphosphonates prevent the Hungry Bone Syndrome. Nephron 1996; 74: 729.